Osteoarthritis (OA) is the most common form of arthritis, yet has historically lagged far behind
rheumatoid arthritis in terms of drug development. Despite the many challenges presented …

The prevalence of osteoarthritis (OA) and the burden associated with the disease are
steadily increasing worldwide, representing a major public health challenge for the coming …

Introduction: Osteoarthritis (OA) is the leading cause of pain, loss of function, and disability
among elderly, with the knee the most affected joint. It is a heterogeneous condition …

New treatment options are needed for osteoarthritis (OA) to slow down the structural
progression of the disease; current therapies mostly target pain and function with minimal …

Osteoarthritis (OA) is a prevalent and severely debilitating disease with an unmet medical
need. In order to alleviate OA symptoms or prevent structural progression of OA, new drugs …

Osteoarthritis (OA) is a degenerative joint disease in which structural changes of hyaline
articular cartilage, subchondral bone, ligaments, capsule, synovium, muscles, and …

Current advances in therapies for osteoarthritis : Current Opinion in Rheumatology Current
advances in therapies for osteoarthritis : Current Opinion in Rheumatology Log in or Register …

Osteoarthritis year 2010 in review: pharmacological therapies - ScienceDirect Skip to main
contentSkip to article Elsevier logo Journals & Books Search RegisterSign in View PDF …

Osteoarthritis (OA) is the most common joint disease and a leading cause for impaired
function and disability with significant treatment costs and socio-economic burden. Despite …

Introduction: Osteoarthritis (OA), the most prevalent form of joint disease, affects as much as
13% of the world's population. In the USA, it is the leading cause of disability in people over …